Market Place
Sourcing Support
FDA Approves KEYTRUDA Plus Pemetrexed Combo For Mesothelioma
18 Sep 2024 //
BUSINESSWIRE
Shilpa Medicare launches Pemetrexed injection
19 Apr 2024 //
INDINPHARMAPOST
FDA approves J&J`s combination therapy for a type of lung cancer
02 Mar 2024 //
REUTERS
Lilly`s Retevmo bests Keytruda combo in front-line RET-rearranged lung cancer
05 Aug 2023 //
PRESS RELEASE
Intas Pharmaceuticals Limited on FDA Import Alert List
06 Jun 2023 //
FDA
Lantern Pharma Selects REPROCELL USA to & Support for the pH 2 Harmonic™
03 May 2023 //
BUSINESSWIRE
Baxter`s Pemetrexed Receives Approval in Europe
19 Jan 2023 //
EMA
Lotus acquires Alimta in Taiwan from Eli Lilly for $62 M
15 Dec 2022 //
BIOSPECTRUMASIA
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination
20 Sep 2022 //
GLOBENEWSWIRE
Lantern Pharma Reports Second Quarter 2022 Financial Results
08 Aug 2022 //
BUSINESS WIRE
HERTHENA-Lung02 PIII Trial of Patritumab Deruxtecan Initiated in Patients
08 Aug 2022 //
BUSINESS WIRE
Eli Lilly`s Alimta plunges as new launches shine
04 Aug 2022 //
FIERCEPHARMA
Merck Provides Update on Phase 3 KEYNOTE-921
03 Aug 2022 //
BUSINESSWIRE
Another 14 generics threaten Eli Lilly`s blockbuster chemotherapy Alimta
31 May 2022 //
ENDPTS
Dr. Reddy`s launches generic version of cancer drug Alimta in the U.S.
28 May 2022 //
SEEKING ALPHA
Jiangsu Hansoh Pharma Generic Pemetrexed Receives Approval in the U.S.
25 May 2022 //
FDA
Apotex Inc`s Generic Pemetrexed Receives Approval in the U.S.
25 May 2022 //
FDA
Waverley Pharma Generic Pemetrexed Receives Approval in the U.S.
25 May 2022 //
FDA
Eagle Pharmaceuticals Announces Commercial Availability of PEMFEXY
01 Feb 2022 //
BUSINESSWIRE
Qilu Pharm`s Generic Pemetrexed Receives Approval in the U.S.
28 Jan 2022 //
FDA
Jiangsu Hansoh Pharma`s Generic Pemetrexed Receives Approval in the U.S.
17 Dec 2021 //
FDA
Innovent Releases ORIENT-31 Phase 3 Study Results in EGFR-mutated NSCLC
20 Nov 2021 //
PRNEWSWIRE
As Lilly gears up for launches, existing meds post solid growth
26 Oct 2021 //
FIERCEPHARMA
Apotex`s Generic Pemetrexed Receives Tentative Approval in the US
06 Oct 2021 //
FDA
Cantargia expands nadunolimab development in NSCLC
06 Sep 2021 //
PRNEWSWIRE
Hospira`s Pemetrexed Receives Tentative Approval in US
11 Jan 2021 //
FDA
EVER Pharma gains EU marketing authorization for value-added Pemetrexed
15 Dec 2020 //
PRESS RELEASE
Innovent and Lilly Release Trial Results of Sintilimab in Combination ALIMTA®
09 Aug 2020 //
PRNEWSWIRE
CMS Establishes Unique J-Code for Eagle Pharmaceuticals’ PEMFEXY™
09 Jul 2020 //
BUSINESSWIRE
CMS Establishes Unique J-Code for Eagle Pharmaceuticals’ PEMFEXY™
09 Jul 2020 //
BUSINESSWIRE
Innovent & Eli Lilly Announce NMPA Acceptance of a snda for Sintilimab
23 Apr 2020 //
PR NEWSWIR
U.S. District Court in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit
31 Dec 2019 //
PR NEWSWIRE
Eagle Pharmaceuticals Reaches Settlement Agreement with Eli Lilly for PEMFEXY
14 Dec 2019 //
BUSINESSWIRE
Results from STELLAR Trial of Tumor Treating Fields with Chemotherapy
16 Oct 2019 //
BUSINESSWIRE
China expands drug bulk-buy program, puts pressure on pharma firms
25 Sep 2019 //
REUTERS
Roche`s Tecentriq excels in another lung cancer study
13 Sep 2019 //
ENDPOINTSNEWS
U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta
03 Sep 2019 //
CNBC
Tentative approval of Alimta generic sends Mylan upwards
30 Aug 2019 //
THE PHARMALETTER
Eli Lilly & Co. v. Hospira, Inc. (Fed. Cir. 2019)
13 Aug 2019 //
PATENTDOCS
Roche, Merck, Novartis and others hike prices on 83 meds starting in July
10 Jul 2019 //
FIERCE PHARMA
Hansoh grabs $1B windfall in the latest China pharma IPO
08 Jun 2019 //
ENDPTS
Novocure nets approval for electric-field mesothelioma therapy
24 May 2019 //
FIERCE BIOTECH
Three major pharmaceutical companies just reported earnings here’s how they did
30 Apr 2019 //
CNBC
With Alimta patent cliff looming, Lilly plots stronger foothold in NSCLC Cyramza
13 Mar 2019 //
ENDPTS
FDA Expands Lilly`s pemetrexed Label with pembrolizumab & Pt Chemo for NSCLC
31 Jan 2019 //
PR NEWSWIRE
New Year’s Day price hikes on blockbuster drugs set the stage for a big debate
03 Jan 2019 //
ENDPTS
Genentech’s TECENTRIQ+Pemetrexed+Pt-Chemo Reduced Disease in Adv`d Lung Cancer
25 Sep 2018 //
BUSINESSWIRE
FDA Action Alert: Merck, Insmed and Antares Pharma
24 Sep 2018 //
Innovent presents clinical data of Sintilimab
20 Sep 2018 //
BIOSPECTRUM ASIA
EC green-lights MSD’s Keytruda combo for lung cancer
11 Sep 2018 //
PHARMA TIMES
Fosun Pharma ‘massively’ fakes API production data - whistleblower
01 Sep 2018 //
FIERCE PHARMA
FDA Approves Expanded Label for Pembrolizumab with Pemetrexed
20 Aug 2018 //
BUSINESSWIRE
US priority review for Keytruda/chemo combo in first-line squamous NSCLC
03 Jul 2018 //
PHARMA TIMES
Dr Reddy`s loses patent case with Eli Lilly over Alimta
25 Jun 2018 //
ECONOMIC TIMES
Krka, d.d. Pemetrexed Receives Approval In Europe
09 Jun 2018 //
EMA
US nod for Alimta/Keytruda lung cancer combo
07 Jun 2018 //
PHARMA TIMES
FDA Expands ALIMTA® Label to Include KEYTRUDA® (pembrolizumab) & Carboplatin
05 Jun 2018 //
PR NEWSWIRE
Opdivo leads Keytruda in U.S. sales—but not for long: analyst
02 Jun 2018 //
FIERCE PHARMA
FDA Review to Merck’s sBLA for KEYTRUDA® (pembrolizumab),Pemetrexed (ALIMTA®)
30 Apr 2018 //
BUSINESSWIRE
